ELYSIUM BIOSCIENCES
Dead / Abandoned — Abandoned — no statement of use filed (as of 15 Oct 2025)
What this means for you
This application is over — abandoned 15 Oct 2025. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 97213296
- Mark type
- Stylized text
- Filed
- 11 Jan 2022
- Published for opposition
- 21 Mar 2023
- Abandoned
- 15 Oct 2025
- Attorney of record
- Michael R Rizzo
Goods and services
- Class 005 — Pharmaceuticals: pharmaceuticals for the treatment and prevention of aging or age-related disorders or diseases; pharmaceuticals for the treatment and prevention of neurodegenerative diseases or disorders
- Class 042 — Scientific and technological services: pharmaceutical research and development services
Owner
- Elysium Health, Inc., New York, NY, US
- Elysium Health, Inc., New York, NY, US
Prosecution history
- 15 Oct 2025 — ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
- 15 Oct 2025 — ABANDONMENT - NO USE STATEMENT FILED
- 04 Nov 2024 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 04 Nov 2024 — SOU EXTENSION 3 GRANTED
- 04 Nov 2024 — SOU EXTENSION 3 FILED
- 04 Nov 2024 — SOU TEAS EXTENSION RECEIVED
- 13 Apr 2024 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 12 Apr 2024 — SOU EXTENSION 2 GRANTED
- 12 Apr 2024 — SOU EXTENSION 2 FILED
- 12 Apr 2024 — SOU TEAS EXTENSION RECEIVED
- 18 Oct 2023 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 16 Oct 2023 — SOU EXTENSION 1 GRANTED
- 16 Oct 2023 — SOU EXTENSION 1 FILED
- 16 Oct 2023 — SOU TEAS EXTENSION RECEIVED
- 16 May 2023 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT